Crisil features in Chartis RiskTech100 2026 for third successive year

Improvesrankingto#36;retainspolepositioninModelValidationcategory Crisil Ltd, the global provider of advanced analytics and credit risk management solutions, has risen one place to #36 in the RiskTech100 2026 report published by Chartis Research this month. This is the third consecutiveyearCrisil has earned a Top 50 ranking, improving steadily from #49 in 2024 to #37 this year, and #36 in […]

Officially Licensed Mutant Football League Merchandise from Bull Airs Brings Monstrous Mayhem to the Masses

CHICAGO, Dec. 03, 2025 (GLOBE NEWSWIRE) — Today, Digital Dreams Entertainment — a studio founded by developers behind SSX on Tour, FIFA Street 2, Need for Speed: Pro-Street, and Army Men: Sarge's Heroes — in partnership with nostalgia-powered pop culture apparel company Bull Airs, announced a new official merchandise line based on the blood-soaked, arcade-style

Crinetics Announces First Patient Dosed in Phase 1/2 Trial Evaluating CRN09682 for the Treatment of Neuroendocrine Tumors and Other Somatostatin Receptor 2-Expressing Tumors

(NASDAQ:CRNX), SAN DIEGO, Dec. 03, 2025 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced the first patient has been dosed in the Phase 1/2 study evaluating CRN09682 in patients with metastatic or locally advanced somatostatin receptor type 2 (SST2)-positive neuroendocrine tumors and other SST2-expressing solid tumors. CRN09682 is the lead candidate from Crinetics'

Enphase Energy Begins Shipments of IQ EV Charger 2 in the United States

(NasdaqGM:ENPH), FREMONT, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced the first production shipments of its next-generation IQ(R) EV Charger 2 to customers across the United States. Designed in a sleek, modern black

Kestra Medical Technologies, Ltd. to Report Second Quarter Fiscal 2026 Financial Results

(NASDAQ:KMTS), KIRKLAND, Wash., Dec. 03, 2025 (GLOBE NEWSWIRE) — Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced that it will report second quarter fiscal 2026 financial results on Thursday, December 11. Management will host a corresponding conference call at 4:30 p.m. Eastern Time. A live and archived

York University joins CIA’s University Accreditation Program

OTTAWA, Dec. 03, 2025 (GLOBE NEWSWIRE) — The Canadian Institute of Actuaries (CIA) is pleased to announce that York University has joined the CIA's University Accreditation Program. York's Actuarial Science Bachelor of Arts (Specialized Honours/Honours Major) program achieved full accreditation by the CIA, reflecting York's commitment to academic excellence and alignment with the CIA's rigorous

Geotab Predicts Quality Data and AI Will Determine Business Survival in 2026

OAKVILLE, ON, Dec. 03, 2025 (GLOBE NEWSWIRE) — Geotab Inc., a global leader in connected vehicles and asset management solutions, today released its 2026 industry predictions. The forecasts focus on the immediate need for businesses to integrate high-integrity data and AI into their core operations to find critical productivity gains and remain competitive in an

Marotta Controls Launches Delta-V, a Comprehensive Line of In-Space Propulsion Components for Next-Gen Satellites

MONTVILLE, N.J., Dec. 03, 2025 (GLOBE NEWSWIRE) — Marotta Controls, a longstanding and leading innovator in aerospace and defense, today announced the launch of its new Delta-V product family, a comprehensive line of in-space propulsion components engineered to meet the needs of modern satellite and spacecraft manufacturers. Developed over the past five years, Delta-V brings

ABM to Announce Fourth Quarter and Full Year 2025 Financial Results

(NYSE:ABM), NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of facility solutions, today announced that it will release its fiscal fourth quarter and full year 2025 financial results on Wednesday, December 17, 2025, before market open. ABM will host its quarterly conference call for all interested parties on Wednesday,

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

(NASDAQ:PCRX), BRISBANE, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the granting of inducement awards on December 1, 2025 to two new employees under Pacira's Amended and Restated 2014 Inducement Plan (the

Scroll to Top